CB 3705
CB 3705 is a dihydrofolate reductase (DHFR) and thymidylate synthetase (TS) inhibitor. CB 3705 inhibits L1210 cells and mutant L1210 cell line (L1210:C15) with ID50s of 4.77 μM and 408 μM, respectively[1][2].
Product Specifications
CAS Number
5854-11-5
UNSPSC
12352005
Target
Dihydrofolate reductase (DHFR) ; Thymidylate Synthase
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(O)CC[C@@H](C(O)=O)NC(C1=CC=C(NCC2=CC3=C(NC(N)=NC3=O)C=C2)C=C1)=O
Molecular Formula
C21H21N5O6
Molecular Weight
439.42
References & Citations
[1]Calvert AH, et al. Quinazoline antifolates with dual biochemical loci of action. Biochemical and biological studies directed towards overcoming methotrexate resistance. Eur J Cancer (1965) . 1980 May;16 (5) :713-22. |[2]Jackman AL, et al. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717) : development, characterization, and cross-resistance studies. Cancer Res. 1986 Jun;46 (6) :2810-5.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880026-500 1x 500 µL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC050017-100 1x 100 µL
Ep-CAM / CD326 (VU-1D9), CF405M conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041879-100 1x 100 µL
Bcl-2 (Apoptosis & Follicular Lymphoma Marker) (rBCL2/796), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681992-500 1x 500 µL
Cytokeratin 20 (KRT20) (Colorectal Epithelial Marker) (KRT20/1992), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740054-500 1x 500 µL
HCG-beta (HCGb/54), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041146-100 1x 100 µL
CD86 (C86/1146), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details